Steven A. Heidler

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

S. Betty Yan, Victoria L. Peek, Rose T. Ajamie et al. · Investigational New Drugs · 2012 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337)

Steven A. Heidler, Jeffrey A Radding · Antimicrobial Agents and Chemotherapy · 1995 · 121 citations

Life Sciences, Genetics, Microbiology +17

Cloning of cDNAs for human phosphoribosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes

Michael A. Becker, Steven A. Heidler, Graeme I. Bell et al. · Genomics · 1990 · 72 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +4

Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene.

Blake J. Roessler, J. M. Nosal, Patrick Smith et al. · Journal of Biological Chemistry · 1993 · 65 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Inositol phosphoryl transferases from human pathogenic fungi

Steven A. Heidler, Jeffrey A Radding · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2000 · 64 citations

Life Sciences, Biochemistry, Microbiology +13